Zai Lab Licenses MediLink Therapeutics' Antibody-Drug Conjugate Platform

MT Newswires01/10 17:39

Reported Earlier, Zai Lab Expands Oncology Pipeline With MediLink Collaboration For Novel LRRC15 ADC ZL-6201

Benzinga01/10 14:06

江海证券：DLL3药物研发热情升温 国产ADC药物前景广阔

智通財経01/08 16:07

港股异动 | 再鼎医药(09688)涨超5% 机构看好其商业化及创新研发持续向好 首予“买入”评级

智通財経01/07 13:52

广发证券：给予再鼎医药(09688)“买入”评级 研发进入全球化新阶段

智通財経01/07 12:43

Zai Lab Secures 300 Million Yuan Debt Facility

MT Newswires01/06 09:07